Ben Goldacre

Ben Goldacre is a British physician, academic, science writer, and campaigner specializing in evidence-based medicine , epidemiology , and the critical analysis of scientific evidence in public discourse and policy. As Director of the Bennett Institute for Applied Data Science at the University of Oxford's Nuffield Department of Primary Care Health Sciences, he leads research into health informatics , clinical trial transparency, and the use of large-scale electronic health records to identify variations in care and inform better outcomes. Trained in medicine at Oxford and University College London , psychiatry at the Maudsley Hospital , and epidemiology at the London School of Hygiene & Tropical Medicine , Goldacre has developed open-source tools such as OpenPrescribing, which tracks prescribing patterns for over 150,000 users annually, and OpenSAFELY, a secure platform analyzing records from 58 million patients to support rapid evidence generation during events like the COVID-19 pandemic .

Goldacre rose to prominence through his decade-long "Bad Science" column in The Guardian , exposing flaws in media reporting of scientific studies, pseudoscientific claims, and regulatory shortcomings. His book Bad Science (2008), which sold over 500,000 copies and topped UK non-fiction charts, dissected topics from nutritionism to homeopathy , emphasizing the need for rigorous empirical scrutiny over anecdotal or distorted evidence. In Bad Pharma (2012), he detailed how pharmaceutical companies suppress unfavorable trial data, manipulate study designs, and influence regulators, arguing that these practices distort medical evidence and harm patients by prioritizing commercial interests over causal transparency in drug efficacy and safety.

A key achievement is his co-founding of the AllTrials campaign in 2013, which demands that all clinical trials—past and present—be registered and fully reported to prevent selective publication bias that skews evidence bases; the initiative has garnered support from over 50,000 individuals, major patient groups, and institutions including GlaxoSmithKline. Goldacre's advocacy extends to government reviews, such as his 2013 analysis for the UK Department for Education on using randomized trials in policy and a 2022 review on NHS data utilization for research, underscoring his commitment to data-driven, reproducible decision-making. While his critiques of industry and media practices have drawn pushback from vested interests, they align with empirical demands for complete datasets to enable independent verification rather than reliance on curated narratives.

Ben Goldacre was born on 20 May 1974 in London to Michael Goldacre, an epidemiologist and professor of public health at the University of Oxford , and Susan Traynor, who performed as the lead singer Noosha Fox in the 1970s pop band Fox . His father's academic career in epidemiology , including research on public health outcomes and vaccine safety, provided an environment steeped in scientific inquiry, while his mother's involvement in the music industry introduced elements of creative performance. Details of Goldacre's childhood experiences, such as schooling or formative influences beyond his parents' professions, have not been extensively documented in public sources, reflecting a preference for privacy on personal matters.

Goldacre commenced his medical education at the University of Oxford's Magdalen College, earning a first-class Bachelor of Arts degree in physiological sciences in 1995. He subsequently pursued clinical training at University College London Medical School, qualifying with a Bachelor of Medicine, Bachelor of Surgery (MB BS) degree.

After qualification, Goldacre specialized in psychiatry , completing his training at the Maudsley Hospital in London . He later advanced his academic expertise through training in epidemiology at the London School of Hygiene and Tropical Medicine.